Welcome. If you're a registered user, please log-in. If not, please sign-up.
  • registrations@informa-ls.com
  • phone:+44(0)20 7017 7481
  • GO

The 19th Annual EU Pharmaceutical Law Forum

Leading legal opinion on the years most high profile cases and regulatory reforms

The must attend meeting for General Counsel in pharmaceutical companies and lawyers in private practice advising the pharmaceutical sector.  Don’t miss this opportunity to get a complete round-up of the past 12 months most important legal decisions and get business critical information on key areas for 2010.

 

Feedback from and access to officials from European Medicines Agency and EU Commission

 

  • Nathalie Rampal Olmedo, Legal Adviser, Legal Service, European Medicines Agency
  • Blaz Visnar, European Commission
  •  Olivér Várhelyi, Head of Unit, Internal Market and Services DG, Industrial Property Unit (D2), European Commission

Top level legal know-how

Top level legal know-how

Marleen Van Kerckhove Partner Arnold & Porter

dr Grant Castle Partner Covington and Burling LLP

Trevor Cook Partner Bird & Bird LLP

Nick Beckett Partner CMS Cameron McKenna LLP

Kristina Nordlander Partner Sidley Austin LLP

Adela Williams Partner Arnold Porter LLP

Tanguy Van Overstraeten Partner Linklaters LLP

Maria Isabel Manley Partner Bristows


..

Event Sponsors

..
..
..
..

Media Partners

..

Dates and Venues

06 May 2010 - 07 May 2010

HOTEL LE PLAZA, Brussels, Belgium

Those who attend include senior legal professionals from in-house counsel and private practice

  • Advocaat
  • Associate
  • Attorney
  • Chief Legal Officer
  • Corporate Counsel
  • Corporate Regulatory Affairs Manager
  • Director Legal Affairs
  • Head Legal Affairs
  • Managing Partner

Attendees to date

Advokatfirman Delphi-Senior Associate Elan Pharma International Ltd-Vice President Legal & Counsel Genzyme Europe BV-Senior Director Legal Europe Shire Pharmaceuticals Group-Legal Counsel Biogen Idec International GmbH-International Counsel KNMP-Lawyer
Amgen Europe GmbH-VP Legal Affairs Amgen Europe GmbH-Senior Counsel Gorrissen Federspiel Kierkegaard-Partner Attorney at Law Almati International Trust Amgen Europe GmbH-Associate Counsel Amgen Europe GmbH-Associate General Counsel
Mehmet Gun & Partners-Partner Arthur Cox-Partner Kancelaria Radcy Prawnego-Partner Arthur Cox-Partner Studio Legale Bird & Bird-Lawyer Napp Pharmaceauticals-Senior legal advisor
Mehmet Gun & Partners-Advocate Sanofi Aventis Groupe-Associate Vice President Advokatfirman Delphi-Part GlaxoSmithKline Biologicals SA-Director Senior Counsel Biogen Idec International GmbH-International Counsel Bird & Bird-Senior Associate
Kroman Reumert-Attorney Wolf Theiss-Partner Shire Pharmaceuticals Group-Vice President Houthoff Buruma-Attorney at Law Johnson & Johnson-Assistant General Counsel Pavia e Ansaldo-Partner
AstraZeneca-Senior Counsel Allergan Ltd-VP & General Counsel Vejmelka & Wuensch VOS-Partner European Medicines Agency-Legal Adviser GlaxoSmithKline Biologicals SA-Director Mehmet Gun & Partners-Advocate
Wolf Theiss-Attorney Sanofi Aventis SpA-Legal Manager Shire Pharmaceuticals Group-Senior Vice President Kroman Reumert-Partner Amgen-Associate General Counsel Oppenlander Rechtsanwalte-Partner
Johnson & Johnson-Senior Legal Counsel Amgen Europe GmbH-Senior Counsel Arthur Cox-Solicitor Biogen Idec International GmbH-Vice President Baker & Mckenzie-Partner

5 May 2010: New 1/2 day workshop

How to Manage an Outsourcing Transaction to Ensure Regulatory Compliance and Get Best Value


3 Key Sessions

  • Outsourcing – A risk analysis
  • Strategies to mitigate regulatory risks in outsourcing deals
  • Strategies to minimise commercial risks and drive best value from an outsourcing transaction

 

Led by: Toby Crick, hazel Grant & Georgia Gavriilidou, Bristows

..

Networking Drinks Host

..
..
..

Global Pharmaceutical Law

Informa Lifesciences are currently investigating interest levels in a new conference on Global Pharmaceutical Law. We'd be grateful for your thoughts and feedback as this will help us determine which regions we should focus on and the topics that we should include. 
Your response to just 5 questions will help us shape this exciting new conference for legal professionals working in the pharmaceutical industry.

 

Media Partners

Media Partners
Media Partners
Media Partners
Media Partners
Media Partners

Poll

What area of the EU’s current regulatory framework on biosimilars is most in need of reform?

 
 




 

Reviews

"An invaluable review of recent developments in EU pharma law and a unique insight into what is coming Partner"
BCM
Hanby Wallace
"Very informative with good presentations with very good knowledge"
ML
Lawyer and PartnerLopes Dias & Associados

Bookmark and Share